Topics

Retrospective Results Show High pCR With Dose-Dense Regimen in HER2+ Breast Cancer

16:00 EST 14 Feb 2020 | OncLive

Jasmeet C. Singh, MD, discusses the findings of a retrospective analysis and how they may impact treatment for patients with HER2-positive breast cancer.

Original Article: Retrospective Results Show High pCR With Dose-Dense Regimen in HER2+ Breast Cancer

NEXT ARTICLE

More From BioPortfolio on "Retrospective Results Show High pCR With Dose-Dense Regimen in HER2+ Breast Cancer"

Quick Search

Relevant Topic

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...